StockData
Profusa, Inc. logo

Profusa, Inc. (PFSA) stock

PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.35−0.06 (-14.22%)

Close on Nov 17, 2026Market cap $46.04KP/E –Yield –

Profusa operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Profusa's operating cash flow for the twelve months ending Jun 30, 2026 was -$20.33M. For fiscal 2025 it was -$16.25M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$16.25M–
FY2024Dec 31, 2024-$2.07M–
FY2023Dec 31, 2023-$2.06M–
FY2022Dec 31, 2022-$581.19K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.63M–
Q1 FY2026Mar 31, 2026-$2.58M–
Q4 FY2025Dec 31, 2025-$5.13M–
Q3 FY2025Sep 30, 2025-$9.99M–
Q2 FY2025Jun 30, 2025-$589.00K–
Q1 FY2025Mar 31, 2025-$537.00K–
Q4 FY2024Dec 31, 2024-$238.00K–
Q3 FY2024Sep 30, 2024-$1.15M–
Q2 FY2024Jun 30, 2024-$394.88K–
Q1 FY2024Mar 31, 2024-$280.85K–
Q4 FY2023Dec 31, 2023-$345.21K–
Q3 FY2023Sep 30, 2023-$479.78K–
Q2 FY2023Jun 30, 2023-$273.27K–
Q1 FY2023Mar 31, 2023-$966.61K–
Q4 FY2022Dec 31, 2022-$179.35K–
Q3 FY2022Sep 30, 2022-$107.86K–
Q2 FY2022Jun 30, 2022-$63.63K–
Q1 FY2022Mar 31, 2022-$230.35K–

More Profusa figures

See a number that looks wrong?